Clopidogrel en es it fr

Clopidogrel Brand names, Clopidogrel Analogs

Clopidogrel Brand Names Mixture

  • No information avaliable

Clopidogrel Chemical_Formula


Clopidogrel RX_link

Clopidogrel fda sheet

Clopidogrel FDA

Clopidogrel msds (material safety sheet)

Clopidogrel MSDS

Clopidogrel Synthesis Reference

D. Aubert et al.; U.S. Pat. 4,529,596(1985)

Clopidogrel Molecular Weight

321.822 g/mol

Clopidogrel Melting Point


Clopidogrel H2O Solubility

50.78 mg/L

Clopidogrel State


Clopidogrel LogP

No information avaliable

Clopidogrel Dosage Forms

Tablet (round, biconvex, film-coated)

Clopidogrel Indication

For the reduction of atherosclerotic events (myocardial infarction, stroke, and vascular death) in patients with atherosclerosis documented by recent stroke, recent myocardial infarction, or established peripheral arterial disease

Clopidogrel Pharmacology

Clopidogrel, an antiplatelet agent structurally and pharmacologically similar to ticlopidine, is used to reduce atherosclerotic events such as myocardial infarction, stroke, and vascular death in patients who have had a recent stroke, recent MI, or have established peripheral vascular disease.

Clopidogrel Absorption

Absorption is at least 50% based on urinary excretion of clopidogrel-related metabolites. Bioavailability has not been found to be affected by food.

Clopidogrel side effects and Toxicity

Symptoms of acute toxicity include vomiting (in baboons), prostration, difficult breathing, and gastrointestinal hemorrhage.

Clopidogrel Patient Information

Patients should be told that they may bleed more easily and it may take them longer than usual to stop bleeding when they take Plavix or Plavix combined with aspirin, and that they should report any unusual bleeding to their physician. Patients should inform physicians and dentists that they are taking Plavix and/or any other product known to affect bleeding before any surgery is scheduled and before any new drug is taken.

Clopidogrel Organisms Affected

Humans and other mammals